Literature DB >> 26958302

Desiderata for Major Eligibility Criteria in Breast Cancer Clinical Trials.

Matthew L Paulson1, Chunhua Weng1.   

Abstract

Use of major eligibility criteria is a popular but unstudied folk practice for improving patient screening efficiency for clinical studies. This mixed-methods research study derived the desiderata for major eligibility criteria in breast cancer clinical trials. We randomly selected thirty interventional breast cancer clinical trials conducted at The New York-Presbyterian Hospital on the Columbia University Medical Center campus to create training (N=20) and testing (N=10) datasets. We utilized the Think-aloud protocol to gauge how clinical researchers identify and use major eligibility criteria to prescreen patients for clinical trials during an audio-recorded interview. A focus group session was held to understand the current prescreening process and investigate how it could be optimized to maximize recruitment rates. Using the grounded theory method, we annotated transcriptions to discover user rationale and desiderata behind major eligibility criteria in breast cancer clinical trials, which were later evaluated in a follow-up survey.

Entities:  

Mesh:

Year:  2015        PMID: 26958302      PMCID: PMC4765677     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  16 in total

1.  Getting the focus and the group: enhancing analytical rigor in focus group research.

Authors:  P S Kidd; M B Parshall
Journal:  Qual Health Res       Date:  2000-05

2.  Modeling data and knowledge in the EON guideline architecture.

Authors:  S W Tu; M A Musen
Journal:  Stud Health Technol Inform       Date:  2001

3.  A practical method for transforming free-text eligibility criteria into computable criteria.

Authors:  Samson W Tu; Mor Peleg; Simona Carini; Michael Bobak; Jessica Ross; Daniel Rubin; Ida Sim
Journal:  J Biomed Inform       Date:  2010-09-17       Impact factor: 6.317

Review 4.  Metabolomics-based systems biology and personalized medicine: moving towards n = 1 clinical trials?

Authors:  Jan van der Greef; Thomas Hankemeier; Robert N McBurney
Journal:  Pharmacogenomics       Date:  2006-10       Impact factor: 2.533

5.  Analysis of eligibility criteria representation in industry-standard clinical trial protocols.

Authors:  Sanmitra Bhattacharya; Michael N Cantor
Journal:  J Biomed Inform       Date:  2013-06-12       Impact factor: 6.317

6.  Usability testing in medical informatics: cognitive approaches to evaluation of information systems and user interfaces.

Authors:  A W Kushniruk; V L Patel; J J Cimino
Journal:  Proc AMIA Annu Fall Symp       Date:  1997

7.  Qualitative research. Introducing focus groups.

Authors:  J Kitzinger
Journal:  BMJ       Date:  1995-07-29

8.  The Diabetes Prevention Program: recruitment methods and results.

Authors:  Richard R Rubin; Wilfred Y Fujimoto; David G Marrero; Tina Brenneman; Jeanne B Charleston; Sharon L Edelstein; Edwin B Fisher; Ruth Jordan; William C Knowler; Lynne C Lichterman; Melvin Prince; Patricia M Rowe
Journal:  Control Clin Trials       Date:  2002-04

9.  Systems biology: confronting the complexity of cancer.

Authors:  Andrew J Gentles; Daniel Gallahan
Journal:  Cancer Res       Date:  2011-09-06       Impact factor: 12.701

10.  Feasibility trial of letrozole in combination with bevacizumab in patients with metastatic breast cancer.

Authors:  Tiffany A Traina; Hope S Rugo; James F Caravelli; Sujata Patil; Benjamin Yeh; Michele E Melisko; John W Park; Stephanie Geneus; Matthew Paulson; Jill Grothusen; Andrew D Seidman; Monica Fornier; Diana Lake; Chau Dang; Mark Robson; Maria Theodoulou; Carlos D Flombaum; Larry Norton; Clifford A Hudis; Maura N Dickler
Journal:  J Clin Oncol       Date:  2009-10-19       Impact factor: 44.544

View more
  2 in total

1.  GIST 2.0: A scalable multi-trait metric for quantifying population representativeness of individual clinical studies.

Authors:  Anando Sen; Shreya Chakrabarti; Andrew Goldstein; Shuang Wang; Patrick B Ryan; Chunhua Weng
Journal:  J Biomed Inform       Date:  2016-09-04       Impact factor: 6.317

2.  The Data Gap in the EHR for Clinical Research Eligibility Screening.

Authors:  Alex Butler; Wei Wei; Chi Yuan; Tian Kang; Yuqi Si; Chunhua Weng
Journal:  AMIA Jt Summits Transl Sci Proc       Date:  2018-05-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.